US Patent Issued to Eligo Bioscience on Nov. 4 for "Phage-derived particles for in situ delivery of DNA payload into C. acnes population" (French Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,216, issued on Nov. 4, was assigned to Eligo Bioscience (Paris).

"Phage-derived particles for in situ delivery of DNA payload into C. acnes population" was invented by Aymeric Leveau (Paris), Ines Canadas Blasco (Paris), Aurelie Mathieu (Paris) and Antoine Decrulle (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to C. acnes carrying DNA vectors with a C. acnes phage packaging signal and a gene of interest. The invention encompasses a C. acnes producer cell carrying DNA vectors, with a C. acnes phage packaging signal and a gene of interest, for the production of phage-derived particles that can robustly transduce C. acnes r...